4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001104659-22-093784
Chief Financial Officer sold 11,655 shares at an average $13.08 ($152,432)
- Chief Financial Officer acquired 5,972 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
WENTWORTH KORY JAMES · Chief Financial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-19 | Exercise or conversion : show line 1 in the form | +4,452 | $2.10 | $9,349 | 24,673 | D |
| 2022-08-19 | Sale : show line 2 in the form | −8,529 | $13.08 | $111,530 | 16,144 | D |
| 2022-08-22 | Exercise or conversion : show line 3 in the form | +117 | $2.10 | $246 | 16,261 | D |
| 2022-08-22 | Sale : show line 4 in the form | −217 | $13.00 | $2,822 | 16,044 | D |
| 2022-08-23 | Exercise or conversion : show line 5 in the form | +1,403 | $2.10 | $2,946 | 17,447 | D |
| 2022-08-23 | Sale : show line 6 in the form | −2,909 | $13.09 | $38,080 | 14,538 | D |
| Open-market sales · 11,655 sh · avg $13.08 · $152,432 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-08-19 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −4,452 | 111,444 | D |
| 2022-08-22 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −117 | 111,327 | D |
| 2022-08-23 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −1,403 | 109,924 | D |
Loading xslF345X03/tm2224405-1_4seq1.xml…